Explore Watchlists Pricing

HISAMITSU PHARMACEUTICAL CO.,INC. (4530) Balance sheet

Market cap

¥514.8B

P/E ratio

19.9x

Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/02	2015/02	2016/02	2017/02	2018/02	2019/02	2020/02	2021/02	2022/02	2023/02	2024/02	2025/02	2026/02
Cash and cash equivalents	-	71,298	81,584	80,280	117,189	110,283	107,051	114,254	129,290	122,154	112,459	114,518	108,859
Marketable securities, current	-	25,192	30,895	32,767	14,759	20,946	34,878	21,743	13,141	14,714	12,862	14,598	9,779
Accounts receivable, net	-	46,587	37,638	36,087	35,185	39,961	49,232	39,546	38,505	40,014	43,237	47,223	56,584
Inventories	-	8,762	8,105	10,615	10,142	8,519	8,816	11,359	8,919	10,330	11,501	12,044	13,971
Total current assets	-	165,315	171,760	172,097	190,065	193,569	209,251	198,061	200,176	199,174	194,022	203,788	205,909
Property, plant and equipment, net	-	45,003	43,851	43,031	40,064	39,556	38,596	37,354	39,069	43,209	49,462	59,899	60,519
Marketable securities, non-current	-	48,779	48,234	49,989	57,169	53,520	48,379	54,602	52,519	60,845	67,121	60,222	80,668
Total non-current assets	-	120,125	113,194	106,722	109,847	103,942	98,150	101,800	102,681	114,742	134,756	139,280	161,253
Total assets	-	285,440	284,954	278,820	299,913	297,512	307,401	299,861	302,858	313,917	328,779	343,068	367,162
Accounts payable	-	9,928	7,669	8,005	7,709	8,290	10,488	7,672	7,533	8,351	9,612	9,910	11,245
Short-term debt	-	1,685	1,683	1,561	1,461	1,361	1,209	1,111	1,071	1,071	1,071	1,065	907
Total current liabilities	-	44,299	40,997	32,425	34,938	30,354	41,055	30,057	32,160	42,578	45,938	47,226	50,418
Total non-current liabilities	-	19,086	17,862	17,189	19,747	18,996	15,598	15,994	15,812	12,931	15,758	16,434	22,048
Total liabilities	-	63,386	58,859	49,614	54,686	49,350	56,654	46,051	47,972	55,509	61,696	63,661	72,467
Retained earnings	-	199,990	210,725	224,214	236,342	248,687	230,929	233,376	236,192	235,569	242,578	257,881	230,653
Stockholders' equity	196,308	222,054	226,095	229,205	245,227	248,161	250,746	253,809	254,885	258,408	267,082	279,407	294,694
Working capital	-